Bo Dong Selected Research

Curcumin

1/2018	In vitro/vivo drug release and anti-diabetic cardiomyopathy properties of curcumin/PBLG-PEG-PBLG nanoparticles.
1/2014	Curcumin Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm by Inhibition of Inflammatory Response and ERK Signaling Pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Dong Research Topics

Disease

28	Neoplasms (Cancer) 02/2024 - 07/2010
18	Inflammation (Inflammations) 01/2024 - 10/2011
13	Atherosclerosis 01/2024 - 04/2005
13	Infections 09/2023 - 11/2005
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 06/2015
9	Fibrosis (Cirrhosis) 02/2024 - 11/2010
7	Myocardial Infarction 12/2023 - 11/2010
7	Glioma (Gliomas) 03/2022 - 07/2010
7	Diabetic Cardiomyopathies 01/2021 - 02/2012
6	Abdominal Aortic Aneurysm 01/2020 - 01/2014
6	Atherosclerotic Plaque (Atheroma) 08/2017 - 07/2008
5	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 01/2016
5	Reperfusion Injury 10/2018 - 01/2017
4	Necrosis 01/2024 - 12/2006
4	Pneumonia (Pneumonitis) 11/2023 - 01/2019
4	Coronary Disease (Coronary Heart Disease) 11/2023 - 01/2014
4	Hemorrhage 08/2021 - 03/2001
4	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2018
3	Hyperglycemia 12/2023 - 02/2012
3	Esophageal Neoplasms (Esophageal Cancer) 11/2022 - 08/2021
3	Hypoxia (Hypoxemia) 05/2022 - 10/2018
3	Adenocarcinoma of Lung 10/2021 - 01/2021
3	Hyperlipidemias (Hyperlipidemia) 01/2021 - 02/2017
3	Wounds and Injuries (Trauma) 12/2020 - 03/2007
3	Ischemia 08/2020 - 01/2017
3	Hematoma 01/2019 - 12/2017
3	Myocardial Ischemia (Ischemic Heart Diseases) 11/2017 - 07/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2014 - 04/2013
3	Thrombocytopenia (Thrombopenia) 08/2004 - 06/2000
2	Metrorrhagia (Spotting) 05/2024 - 07/2019
2	Heart Failure 04/2024 - 12/2020
2	Infarction (Infarctions) 12/2023 - 01/2021
2	Obesity 11/2023 - 01/2022
2	Hypercholesterolemia 08/2023 - 04/2005
2	Osteoporosis 01/2023 - 02/2019
2	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2022
2	Cicatrix (Scar) 11/2022 - 01/2013
2	Diabetic Nephropathies (Diabetic Nephropathy) 05/2022 - 01/2011
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 04/2017
2	Breast Neoplasms (Breast Cancer) 01/2021 - 07/2019
2	Pathologic Processes 01/2021 - 07/2018
2	Pain (Aches) 12/2020 - 10/2020

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 10/2022 - 04/2005
13	Messenger RNA (mRNA)IBA 03/2022 - 04/2005
11	Long Noncoding RNAIBA 11/2023 - 04/2017
9	Apolipoproteins E (ApoE)IBA 01/2024 - 01/2014
9	Angiotensin IIIBA 01/2020 - 07/2008
8	Biomarkers (Surrogate Marker)IBA 12/2023 - 09/2017
8	Prorenin ReceptorIBA 01/2023 - 01/2019
6	EnzymesIBA 01/2024 - 02/2012
6	Interleukin-6 (Interleukin 6)IBA 01/2024 - 04/2015
6	CollagenIBA 11/2023 - 11/2010
6	MicroRNAs (MicroRNA)IBA 12/2021 - 06/2014
5	oxidized low density lipoproteinIBA 01/2024 - 04/2005
5	RNA (Ribonucleic Acid)IBA 08/2023 - 04/2017
5	Therapeutic UsesIBA 05/2023 - 06/2000
5	Small Interfering RNA (siRNA)IBA 12/2021 - 01/2019
5	Angiotensin-Converting Enzyme 2IBA 12/2018 - 07/2009
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 02/2017
4	InflammasomesIBA 01/2023 - 07/2017
4	CateninsIBA 01/2022 - 04/2017
4	angiotensin I (1-7)IBA 01/2020 - 07/2008
4	ApolipoproteinsIBA 01/2020 - 10/2018
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2007
4	CholesterolIBA 06/2015 - 04/2005
3	CytokinesIBA 01/2024 - 01/2004
3	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 11/2007
3	AntioxidantsIBA 01/2023 - 12/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 03/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2022 - 11/2007
3	Transcription Factors (Transcription Factor)IBA 12/2021 - 01/2020
3	salicylhydroxamic acid (SHAM)IBA 01/2020 - 12/2006
3	Cyclin D1IBA 09/2010 - 03/2006
2	CX 5461IBA 03/2024 - 10/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 10/2021
2	ImmunosorbentsIBA 01/2024 - 01/2021
2	ResveratrolIBA 01/2024 - 02/2023
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2024 - 01/2022
2	AlbuminsIBA 11/2023 - 01/2011
2	Carrier Proteins (Binding Protein)IBA 09/2023 - 12/2021
2	Sirtuin 1IBA 02/2023 - 01/2022
2	16S Ribosomal RNAIBA 01/2023 - 08/2020
2	GlucocorticoidsIBA 01/2023 - 03/2011
2	Wiskott-Aldrich Syndrome ProteinIBA 11/2022 - 01/2013
2	EpitopesIBA 10/2022 - 10/2004
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2022 - 01/2011
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 01/2021
2	OsteopontinIBA 03/2022 - 01/2021
2	Complementary DNA (cDNA)IBA 01/2022 - 09/2006
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2021
2	mouse MIRN29 microRNAIBA 01/2022 - 11/2018
2	LipopolysaccharidesIBA 11/2021 - 01/2020
2	Alanine Transaminase (SGPT)IBA 05/2021 - 12/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2019
2	Substance PIBA 10/2020 - 01/2019

Therapy/Procedure

13	Therapeutics 02/2024 - 01/2004
5	Electroacupuncture 10/2020 - 01/2016
4	Drug Therapy (Chemotherapy) 10/2021 - 06/2000
3	Length of Stay 01/2023 - 08/2021
3	Catheters 01/2019 - 10/2018